Text of AZ SB 1451 (2024)
Parental consent; gender reassignment drugs
Legislative text is a public record. Where LegiScan supplied it, the CC BY 4.0 credit applies.
Source: LegiScan. Bill data and text from LegiScan (legiscan.com), licensed CC BY 4.0 and used in modified form. LegiScan does not endorse the Trans Data Initiative. License: CC BY 4.0(opens another site). Source page(opens another site)
As introduced
9,953 characters
REFERENCE TITLE: parental consent; gender reassignment drugs
State of Arizona
Senate
Fifty-sixth Legislature
Second Regular Session
2024
SB 1451
Introduced by
Senator
Shope
An
Act
amending
title 36, chapter 22, article 1, Arizona Revised Statutes, by adding section 36-2273;
relating to the protection of minors.
(TEXT OF BILL BEGINS ON NEXT PAGE)
Be it enacted by the Legislature of the State of Arizona:
Section 1. Title 36, chapter 22, article 1,
Arizona Revised Statutes, is amended by adding section 36-2273, to read:
START_STATUTE36-2273. Parental consent; gender reassignment drugs; minors; exceptions;
violation; classification; definition
A. Except as otherwise provided by
law and subsection D of this section, a person, this state or any political
subdivision of this state may not knowingly engage in or cause any of the
following practices to be performed on a minor if the practice is performed for
the purpose of changing a minor's appearance or body to no longer correspond to
the minor's biological sex without first obtaining written informed consent of
a parent or legal guardian of the minor:
1. Prescribing or administering
gonadotropin releasing hormone analogues or other synthetic drugs used to stop
luteinizing hormone and follicle stimulating hormone secretion, synthetic
antiandrogen drugs used to block the androgen receptor or any drug to suppress
or delay normal puberty.
2. Prescribing or administering
testosterone, estrogen or progesterone to a minor in an amount greater than
would normally be produced endogenously in a healthy individual of that minor's
age and biological sex.
B. A health professional as defined
in section 32-3201 may not knowingly engage in conduct that aids the
practices described in subsection A of this section being performed on a minor
without written informed consent of a parent or legal guardian of the
minor. This section may not be construed to impose liability on any
speech protected by federal or state law.
C. A health care institution as
defined in section 36-401 may not allow the practices described in
subsection A of this section to be performed on a minor in its facilities
without first having received written informed consent from a parent or legal
guardian of the minor.
D. this section does not apply to:
1. Services provided to a person born
with a medically verifiable disorder of sex development, including a person
with external biological sex characteristics that are irresolvably ambiguous,
such as an individual born with forty-six XX chromosomes with
virilization, forty-six XY chromosomes with undervirilization or having
both ovarian and testicular tissue.
2. Services provided to a person when
a physician has otherwise diagnosed a disorder of sexual development, in which
the physician has determined through genetic or biochemical testing that the
person does not have normal sex chromosome structure, sex steroid hormone
production or sex steroid hormone action for a male or female.
3. The treatment of any infection,
injury, disease or disorder that has been caused or exacerbated by the performance
of a procedure described in subsection A of this section, whether or not the
procedure was performed in accordance with state and federal law.
4. Any procedure undertaken because a
person suffers from a physical disorder, physical injury or physical illness
that is certified by a physician and that would place the person in imminent
danger of death or impairment of a major bodily function unless surgery is
performed.
E. A person who violates this section
is guilty of a class 1 misdemeanor.
F. On an adverse decision by the
appropriate health profession regulatory board as defined in section 32-3201,
the provision of services described in subsections A and B of this section to a
minor is considered unprofessional conduct and is subject to discipline by the
health profession regulatory board with jurisdiction over the health
professional.
G. A person may assert an actual or
threatened violation of this section as a claim or defense in a judicial or
administrative proceeding and obtain compensatory damages, injunctive relief,
declaratory relief or any other appropriate relief.
H. A person shall bring a claim for a
violation of this section not later than two years after the day the cause of
action accrues. A minor may bring an action before reaching eighteen
years of age through a parent or guardian and may bring an action in the
minor's own name on reaching eighteen years of age at any time from that point
until twenty years after.
I. An action under this section may
be commenced and relief may be granted in a judicial proceeding without regard
to whether the person commencing the action has sought or exhausted available
administrative remedies.
J. In any action or proceeding to
enforce this section, a prevailing party who establishes a violation of this
section is entitled to recover reasonable attorney fees.
K. The attorney general or the county
attorney for the county in which an alleged violation of this section occurred
may bring an action to enforce compliance with this section. This
section does not deny, impair or otherwise affect any right or authority of the
attorney general, this state or counties in this state or any agency, officer
or employee of this state or counties in this state to institute or intervene
in any proceeding.
L. For the purposes of this section,
"biological sex" has the same meaning prescribed in section 32-3230.
END_STATUTE
Sec. 2. Legislative right of intervention
The legislature, by joint resolution,
may appoint one or more of its members who sponsored or cosponsored this act in
the member's official capacity to intervene or defend the statute as a matter
of right in any case in which the constitutionality or enforceability of this
act or any portion of this act or any rule adopted pursuant to this act is
challenged.
Sec. 3. Legislative findings
The legislature finds that:
1. This state has a
compelling government interest in protecting the health and safety of its
citizens, especially vulnerable children, and the best way to protect the
health and safety of children is to protect the right and responsibility of
parents or legal guardians to make all health care decisions for their minor
child.
2. Section 1-602,
Arizona Revised Statutes, and the common law recognize that parents or legal
guardians have the exclusive right to make all health care decisions for their
minor child, including decisions regarding the appropriate treatment for
children who experience distress at identifying with their sex.
3. To safeguard this right,
families must have a meaningful legal remedy to hold medical professionals
accountable when they administer medical drugs and procedures to a minor child
without obtaining the written informed consent of the minor's parent or legal
guardian.
4. To further safeguard
this right, the state must have the authority to take appropriate remedial
action against medical professionals who refuse to obtain written informed
consent from a minor's parent or legal guardian before administering medical
drugs and procedures.
5. Only a tiny percentage
of the American population experiences distress at identifying with their
sex. According to the American psychiatric association, prevalence
ranges from 0.005 to 0.014 percent for natal adult males and from 0.002 to
0.003 percent for natal females.
6. Studies consistently
demonstrate that the vast majority of children who are gender nonconforming or
experience distress at identifying with their sex come to identify with their
sex in adolescence or adulthood, thereby rendering most medical health care
interventions unnecessary.
7. Scientific studies show
that individuals struggling with distress at identifying with their sex often
have already experienced psychopathology, which indicates these individuals
should be encouraged to seek mental health care services before undertaking any
hormonal intervention.
8. Suicide rates,
psychiatric morbidities and mortality rates remain markedly elevated above the
background population after inpatient gender reassignment procedures have been
performed.
9. Some health care
providers are prescribing puberty-blocking drugs in order to delay the
onset or progression of normally timed puberty in children who experience distress
at identifying with their sex. This is being done despite the lack
of any long-term longitudinal studies evaluating the risks and benefits
of using these drugs for the treatment of such distress or gender transition.
10. Health care providers
are also prescribing cross-sex hormones for children who experience distress at
identifying with their sex, despite the fact that no randomized clinical trials
have been conducted on the efficacy or safety of the use of cross-sex hormones
in adults or children for the purpose of treating such distress or gender
transition.
11. The use of cross-sex
hormones comes with the following serious known risks:
(a) For females,
erythrocytosis, severe liver dysfunction, coronary artery disease,
cerebrovascular disease, hypertension, increased risk of breast and uterine
cancers and irreversible infertility.
(b) For males,
thromboembolic disease, cholelithiasis, coronary artery disease,
macroprolactinoma, cerebrovascular disease, hypertriglyceridemia, breast cancer
and irreversible infertility.
12. The risks of gender
transition procedures far outweigh any benefit at this stage of clinical study
on these procedures.